mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |